FDA

FDA approves drug to reduce risk of serious kidney and heart complications in adults with chronic kidney disease associated with type 2 diabetes

Diabetes Care

The effect of dapagliflozin on albuminuria in DECLARE-TIMI 58

New England Journal of Medicine

New study examines CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis

American Heart Association

Microvascular disease and incident heart failure among individuals with type 2 diabetes mellitus

Journal of the American College of Cardiology

ACC releases expert statement on managing hypertryglyceridemia to reduce ASCVD risk

American Heart Association

American Heart Association/American Stroke Association release a scientific statement on the primary care of adult patients after stroke

Cardiometabolic Beat - New Episode

Adam DeVore, MD, MHS 

Listen in as Dr. Adam DeVore, Cardiologist and Associate Professor of Medicine at Duke University School of Medicine in Durham, North Carolina shares results from the CONNECT-HF trial.

New Planning Committee Member:

New Senior Planning Committee Roles

Women’s Health & Cardiometabolic Risk Educational Planning Advisor:

Ethnic & Racial Disparities in Cardiometabolic Health Educational Planning Advisor: